Details of the Drug

General Information of Drug (ID: DM3XQLD)

Drug Name

ARG201

Indication

Disease Entry	ICD 11	Status	REF
Diffuse systemic sclerosis	4A42.1	Phase 2	[1]
Systemic sclerosis	4A42	Phase 2	[2]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026882)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)